English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduBy itself, AFib isn’t life-threatening, but it can lead to life-threatening consequences. A Penn State Health expert discusses why that flutter in your chest is important and new treatments that are available.
Tag: Afib
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients
Mount Sinai-led study demonstrates significant safety outcomes and could lead to more frequent use of this new technology
Female heart patients less likely to have additional problems fixed during surgery
Two studies led by Michigan Medicine find that female patients who undergo heart surgery are less likely to have secondary ailments corrected during a procedure — despite guidelines that indicate they should. Researchers say it adds to growing evidence that women are undertreated across the spectrum of cardiovasvular care.
Researchers look at how pollution, weather, noise, social factors impact AFib
There’s a growing recognition of how the environment we live in affects our heart health. Atrial fibrillation, a common heart rhythm disorder, affects millions worldwide and can lead to serious health problems. While we’ve studied how genetics and lifestyle play…
Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation
FOR IMMEDIATE RELEASE Contact: Ilana Nikravesh Mount Sinai Press Office 212-241-9200 [email protected] …
Can Technology Help You Keep Watch of Your Heart Health?
Interventional cardiologist Dr. Henry Sun, director of LifeBridge Health’s Cardiovascular Institute, gives the scoop on the heart health monitoring capabilities of smart watches.
MedStar Health offers the first FDA approved treatment for long-standing, persistent atrial fibrillation
Two MedStar Health hospitals are now offering an FDA-approved treatment for patients who have had persistent atrial fibrillation for more than a year. The Hybrid AF™ Convergent Therapy is available both at MedStar Washington Hospital Center and MedStar Union Memorial Hospital in Baltimore.
The Medical Minute: Reducing stroke risk from AFib without blood thinners
To help prevent a stroke — a common and serious risk associated with AFib — patients are treated with blood thinners. But for some, the medication itself can be risky.
New mutation raises risk for AFib, heart failure for people of color
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
Two Blood Thinners at Once: More Risk with the Same Reward
For some patients, adding aspirin to a direct oral anticoagulant is an equation that rarely adds up.
Morristown Medical Center’s Dr. Stephen Winters Discusses What Everyone Should Know About Atrial Fibrillation
September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.
Mount Sinai Cardiologists First on East Coast to Offer New Stroke Prevention Therapy for Heart Patients
New generation implant has improved safety and performance features for those with atrial fibrillation
Intensive Blood Pressure Control Has Potential to Reduce Risk of Atrial Fibrillation
Intensive blood pressure control may reduce the risk of atrial fibrillation (AFib), an irregular heartbeat that can lead to serious complications such as stroke, heart failure and heart attacks, according to scientists at Wake Forest School of Medicine.
Ohio State First in U.S. to Use New Atrial Fibrillation Device
Cardiologists at The Ohio State University Wexner Medical Center are the first in the U.S. to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
Can obesity limit antiarrhythmic drug effectiveness?
A new study from researchers at the University of Illinois at Chicago is the first to show that some antiarrhythmic medications used to treat AFib are less effective in patients who are obese. The results of this study, which followed more than 300 patients in the UIC AFib Registry, are published in JAMA Cardiology.